Versant-backed Gotham Therapeutics launches with $54M round and a new way to connect on mRNA
New York has added another biotech startup to its growing roster for the Big Apple hub.
The company is Gotham Therapeutics, which now has a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.